Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Industry News
12/10/2023
AstraZeneca and AbelZeta to Co-Develop a Novel GPC3 Armored CAR-T Ther...
12/10/2023
WuXi Biologics Successfully Implemented a Fully Integrated Continuous ...
(Free)
12/7/2023
Innovent Biologics and Synaffix Expand ADC Collaboration
12/5/2023
Richter and Mithra Sign Deal to Commercialize Estetrol Containing Prod...
12/5/2023
Merck Group and Abbisko Strike Licensing Deal for Pimicotinib for Chin...
12/4/2023
Aspen Pharma Makes Further Inroads into China by Taking Over Sandoz Ch...
12/4/2023
Tang Capital's Concentra Bio Makes Unsolicited Bid for LianBio
12/4/2023
Novartis to Invest CNY 600M for Second Production Site in Zhejiang
11/30/2023
Financial-related Company News Digest (November 2023)
11/28/2023
Takeda China Expands Collaborations for Digital Healthcare Innovation ...
11/28/2023
Evommune and Accutar Biotech Announce AI Drug Discovery Collaboration
11/27/2023
Moderna Begins Work on Its mRNA China Plant
11/27/2023
Indian Pharma to Benefit amid Big Pharma's China De-Risking
11/27/2023
Coherus Sets Price of China-Made PD-1 Inhibitor Loqtorzi at a 20% Disc...
11/27/2023
AstraZeneca to open Hong Kong R&D centre by late 2024 at earliest with...
11/26/2023
Dizal Strikes Derma Drug JV Deal with Wuxi High-tech Zone
11/26/2023
Zhifei to Acquire Chenan to Expand into Metabolic Disease Drugs
11/23/2023
Myricx Concludes Global Licence Deal for WuXi Bio's Antibody
11/22/2023
Acrometa to Strengthen Biopharma Presence in China by Developing Co-Wo...
(Free)
11/21/2023
Tencent Sets Sights on China's Multibillion-Dollar Healthcare Sector w...
11/21/2023
Bimeda Opens £22M China Plant
11/21/2023
Connect Bio and Simcere Pharma Announce Exclusive License Deal for Rad...
11/21/2023
AstraZeneca and Usynova Strike Global License Deal for KRASG12D Inhib...
11/21/2023
BeiGene and Ensem Therapeutics Announce Partnership to Advance Differe...
11/21/2023
MNCs Unveil Initiatives at CIIE to Deepen Connection with Chinese Pati...
11/20/2023
Aurobindo Pharma's China Plant Gets EU's GMP Approval
(Free)
11/20/2023
Chiesi Signs License Deal with Haisco for a Novel, Reversible DPP1 In...
11/20/2023
Roche to Further Explore China's Personalized Healthcare Market Poten...
11/16/2023
Daewoong Inks MOU with Meheco International to Boost Drug Export to Ch...
11/13/2023
MSD Takes Over AstraZeneca as the Top MNC in China Q3/2023
Page:
5
/
13
Total number of articles:
385
:
[First]
[<<]
[3]
[4]
[5]
[6]
[7]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit